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ABSTRACT 
 
Objective 
To determine the effect of radiotherapy (RT) on intra-plaque neovascularization (IPN) in 
human carotid arteries.  
 
Background 
Exposure of the carotid arteries to RT, during treatment for head and neck cancer (HNC), is 
associated with increased risk of stroke. However, the effects of RT upon IPN – a pre-cursor 
to intraplaque hemorrhage and thus associated with plaque vulnerability – are unknown.  
 
Methods 
Patients that had undergone unilateral RT for HNC ≥ 2 years previously underwent B-mode 
and contrast-enhanced carotid ultrasonography (CEUS) of both RT-side and non-RT side 
arteries.  Presence of IPN during CEUS was judged semi-quantitatively as grade 0 (absent), 
grade 1 (present but limited to plaque base) or grade 2 (extensive and noted within plaque 
body).  
 
Results 
Of 49 patients studied, 38 had plaques. The number of plaques were significantly greater in the 
RT versus the non-RT arteries. Overall, 75% RT-side plaques had IPN vs. 39% non-RT side 
plaques (p=0.002). Amongst patients with plaques, IPN was present in 81% RT-side plaques 
vs. 41% non-RT side plaques (p=0.004). Grade 0 IPN was significantly more common in non-
RT side plaques (25% vs. 61%, p=0.002) whereas Grade 2 plaques were more common on the 
RT side (31% vs. 9%, p=0.03). The only clinical variable which predicted presence or absence 
of IPN was RT laterality. 
 
Conclusion 
This is the first study in humans to reveal that there is a significant association between RT and 
presence and extent of IPN. This may help to explain the etiology of increased stroke risk 
amongst HNC survivors treated by RT.  
 
 
 
Key words 
 
Plaque neovascularization; contrast; contrast-enhanced ultrasound; radiotherapy 
  
INTRODUCTION 
 
Atherosclerosis is a chronic inflammatory condition and the underlying patho-biological 
substrate that accounts for the majority of cardiovascular events. However, not all patients with 
atherosclerosis experience such outcomes. Over the past two decades, much research interest 
has focused upon predicting which atherosclerotic plaques will ‘rupture’ – leading to events 
such as myocardial infarction or stroke – and which plaques do not rupture, leading to the  
concept of the ‘vulnerable’ (or unstable) plaque.(1)  
 
An emerging key feature of such plaques are intra-plaque neovessels. These neovessels are 
fragile, leaky and prone to rupture, leading to intra-plaque hemorrhage, which contributes to 
the necrotic core of plaques and is believed to increase risk of plaque rupture.(2) Consequently, 
the presence of intra-plaque neovascularization (IPN) is widely thought of as a pre-cursor to 
the vulnerable plaque.(3,4) A number of imaging and histological observational studies have 
revealed a clear association between presence and extent of IPN and subsequent cardiovascular 
events, including mortality.(5-7) Much of this research in humans has focused upon the carotid 
arteries, firstly due to their superficial location (favours non-invasive imaging techniques), 
secondly because of the association with stroke and thirdly because patients undergoing carotid 
endarterectomy provide a suitable model for histological comparisons. 
  
IPN can be visualized by several non-invasive imaging techniques, one of which is contrast-
enhanced ultrasound (CEUS). CEUS utilizes manufactured trans-pulmonary ultrasound 
contrast agents, which consist of acoustically-active gas-filled microbubbles. These 
microbubbles, which remain intravascular at all times, are typically slightly smaller than 
erythrocytes, allowing free passage within the circulation and effectively acting as red cell 
“tracers”. Studies have demonstrated that carotid ultrasonography performed following 
administration of contrast permits visualization of IPN (8) and comparisons with histological 
neovessel density have validated the technique’s accuracy.(9) 
 
Radiotherapy (RT) damages arterial walls and promotes atherosclerotic plaque formation. The 
carotid arteries frequently receive significant incidental doses of radiation during RT treatment 
of malignancies, especially head and neck cancers (HNC). Radiation vasculopathy had until 
recently been considered quite a rare entity, as patients would frequently succumb to their 
malignancy first. However, as cancer survival rates improve, patients are “outliving” their 
malignancies and presenting later with the long-term sequelae of cancer therapy.(10) 
 
Several studies have shown that RT of the carotid arteries is associated with increased intima-
media thickness (IMT), increased carotid plaque formation and thus overall an increased risk 
of stroke.(11)  However, although the effects of RT on carotid IMT and plaque burden have 
been documented, the effect of RT on plaque composition – specifically IPN – has not been 
studied in humans. We thus performed this cross-sectional study to assess the effects of RT 
upon IPN in survivors of HNC that had previously received RT.  
 
METHODS 
 
Study Design 
 
This was a cross-sectional study of patients previously treated at a cancer center with RT for 
HNC. Ethical approval for this study was obtained and all patients provided informed written 
consent. The inclusion criteria were as follows: 
 Age >18 years 
 Histologically confirmed cancer treated with hemi-neck RT to ≥ 50Gray (Gy) 
 Radiotherapy administered > 24 months previously 
 Able to provide written informed consent 
 
The exclusion criteria were as follows: 
 
 Patients with active HNC    
 Patients with a prior history of carotid endarterectomy or carotid angioplasty / stenting 
 Patients with bilateral RT 
 Known allergy to sulphur or sulphur-containing drugs 
 
HNC patients who had received unilateral radical RT prior to December 2009 were identified 
via the RT database. Eligible patients were contacted and those agreeable to participation (only 
three patients declined) in the study were then invited to attend for a baseline questionnaire, 
brief physical examination, routine blood tests (including full blood count and biochemistry 
and total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol 
levels) and carotid ultrasonography.  
 
Patient Clinical Variables 
Presence of cardiovascular risk factors were defined as follows: diabetes mellitus (random 
serum glucose ≥ 11.1mmol/L, a glycosylate haemoglobin A1c (HbA1c) ≥5.8%   or current use 
of glucose-lowering agents or insulin), hypertension (systolic blood pressure ≥140 mmHg 
and/or diastolic blood pressure ≥ 90 mmHg or current use of ant-hypertensive agents), 
hyperlipidemia (fasting serum low density lipoprotein (LDL) ≥2.6mmol/L, high density 
lipoprotein (HDL) <2.3mmol/L or triglycerides (TG) ≥2.3mmol/L, or current use of 
cholesterol-lowering agents), ever smoker and family history of premature CAD (first degree 
relative suffered myocardial infarction or stroke, <55yrs (men) or <65yrs (women)). Height (in 
metres) and weight (in kilograms) were recorded in order to calculate body mass index (BMI).  
 
Carotid Ultrasonography 
B-mode, colour Doppler and contrast enhanced carotid ultrasonography were performed using 
a high-resolution ultrasound system (Vivid-7; General Electric Healthcare, Chalfont, Bucks, 
UK) equipped with a broadband linear array (3-11 MHz) transducer, as illustrated in figure 1. 
All scans were performed by cardiologists (BNS & NSC) blinded to the patient’s prior history 
including the laterality of RT. ECG monitoring was performed continuously throughout the 
scan and arterial blood pressure was recorded using an automated sphygmomanometer. In 
summary, the proximal, mid, and distal common carotid artery (CCA), bifurcation of the CCA 
and proximal portion of the internal and external carotid arteries were systematically 
interrogated in long-axis and short-axis views. Color Doppler imaging was used to identify 
flow and spectral Doppler used to measure flow velocities. 
 
Plaque was defined as per the Mannheim consensus as a focal structure encroaching into the 
arterial lumen by >0.5 mm, a distinct area of IMT >50% greater than the adjacent wall or >1.5 
mm in thickness.(12) IMT measurements were taken at the far wall of the distal CCA at end-
diastole using a semi-automated edge detection algorithm (EchoPAC version 8.0, GE 
Healthcare) and the mean value obtained was an average of 3 measurements.  
 
After B-mode images were acquired, an intravenous cannula was inserted and Sonovue 
ultrasound contrast (Bracco Diagnostics, Milan, Italy) was administered as a continuous 
intravenous infusion using a specific pump (Vueject, Bracco, Milan, Italy). Two vials of 
Sonovue (total 8mL) were infused at a standardized rate of 1.2ml/min, providing approximately 
6.5 minutes of contrast opacification. During this time, the right and left carotid arteries were 
re-imaged, with special focus upon areas of abnormality (i.e. plaques) identified during the B-
mode scan. As previously described in a CEUS study with histological validation (9), IPN was 
graded semi-quantitatively as absent (Grade 0), limited to the adventitia / plaque base (Grade 
1) or extensive and/or extending into the plaque body (Grade 2) by a doctor blinded to the side 
of RT. Following the scan, all images were transferred to the EchoPAC database and also stored 
on disc for off-line analysis. 
 
Statistics 
The primary aim of the study was to compare carotid plaques in irradiated arteries to 
unirradiated internal controls.  As previously reported, the expected absolute difference in the 
prevalence of carotid artery stenosis due to plaque is around 25-30% (13-15). With a Type I 
error set at 95% (α = 0.05) and a type II error set at 10% (β = 0.10), a minimum of 80 patients 
would be required.  As patients treated with unilateral RT were evaluated (the contralateral 
carotid artery served as an internal control), a total of 40 patients were therefore required for 
this study. In order to account for unexpected loss of subjects (e.g. poor ultrasound windows, 
withdrawal of consent), the study aimed to recruit a total of 50 patients.  As an increased 
prevalence of carotid plaque was expected on the RT-side, we hypothesized that there may also 
be an accompanying increased incidence of IPN also. 
 
Continuous variables are presented as mean ± standard deviation and categorical variables as 
proportions. Continuous variables were compared using the Student’s t-test and categorical 
variables using Chi-square test. Intra-observer and inter-observer variability were tested for 
using kappa. All statistical calculations were performed using SPSS version 19.0. A p value 
<0.05 was taken as statistically significant for all tests. 
 
RESULTS  
 
Patient Variables 
A total of 50 patients consented for the study, of whom 49 underwent B-mode and contrast-
enhanced carotid ultrasound studies (in one patient it was not possible to obtain intravenous 
access and thus contrast could not be administered). The baseline demographics of these 49 
patients are detailed in Table 1. Mean age was 57±8yrs, 69% were male and mean BMI was 
26.3±4.4 kg/m2. The histological tumour type was squamous cell carcinoma in the majority of 
patients (38/49, 78%).  
 
Almost half the cohort (22/49, 45%) had also received platinum-based chemotherapy drugs for 
treatment of their HNC. The mean time duration from RT to carotid imaging was 5.4±2.5 years 
(range 2.1 – 12.6yrs). Routine full blood count was normal in all patients. Mean serum 
creatinine value was 75±19mmol/L (range 46-128mmol/L). The mean total, HDL and LDL 
cholesterol levels were 5.3mmol/L, 1.5mmol/L and 3.2mmol/L respectively. All patients had 
normal serum calcium concentration (mean 2.2±0.1mmol/L). 
 
 
Carotid Ultrasonography 
 
The data presented in Table 2 demonstrates the differences in plaque number, area and 
prevalence of IPN from the RT and non-RT carotid arteries. Of the 49 patients examined, 
plaques were detected in 38 (78%). There were a greater number of plaques on the RT side 
although mean plaque area and total plaque burden by area were similar between RT and non-
RT arteries.  
 IPN was analyzed on a per-patient as well as per-plaque basis, but in both cases, IPN was more 
commonly seen on the RT side than the non-RT side. IPN was visualized in 75% plaques from 
the RT-side artery vs. just 39% from non-RT arteries. The absence of IPN (i.e. Grade 0) was 
significantly more frequent in non-RT plaques than RT plaques. Conversely, Grade 2 IPN – 
the highest grade and indicative of the most extensive IPN – was significantly more commonly 
identified in RT plaques than in non-RT plaques. Figures 2 shows a patient with a large plaque 
but without IPN (i.e. Grace 0) whereas figures 3 and 4 illustrate patients with IPN clearly seen 
during CEUS imaging.    
 
We examined the impact of patient variables on presence or absence of IPN, both in all patients 
and the patients with IPN on the RT side plaques only and these results are shown in table 3. 
In summary, there was no statistical relationship between presence or absence of IPN and 
gender, smoking history, body weight, prior treatment with chemotherapy, time duration since 
RT or prior use of aspirin. Patients taking statins were less likely to have IPN than patients not 
on statin therapy, though this had borderline statistical significance (p=0.053). Inter-observer 
variability for both presence / absence of IPN and for grade of IPN had a kappa value of 1.0. 
 
 
DISCUSSION 
 
This is the first study to assess the impact of RT upon plaque neovascularization. Our results 
have shown that IPN is significantly increased in plaques from arteries exposed to RT 
compared to arteries that did not receive RT. Irrespective of whether our data were analyzed 
on a per-patient or per-plaque basis, IPN was more common in RT-side plaques and extensive 
IPN – Grade 2 – was also significantly more frequent on the RT side than non-RT side. These 
findings were independent of age, gender, smoking status, time duration since RT, drugs 
(including aspirin, statins and chemotherapy) and BMI. Indeed, the only variable associated 
with presence of IPN was RT laterality. 
 
The pathophysiology of radiation vasculopathy is poorly understood, in large part due to the 
lack of a definitive clinicopathologic study in humans. Three mechanisms have been proposed 
– ischemic necrosis (due to occlusion of the vasa vasorum), adventitial fibrosis (leading to 
external arterial compression) and accelerated atherosclerosis.(16) Animal studies have given 
an insight into the changes seen in arterial walls with time following RT, progressing from 
initial endothelial damage and then thickening to adventitial fibrosis and necrosis of the media 
also.(17)  
 
However, it is widely believed that the initial injury to the vasa vasorum is a key feature of RT-
related arterial disease, though it has remained unclear whether this process is predominantly 
inflammatory or ischemic in nature (ischemia secondary to microthrombosis / occlusion of the 
vasa vasorum).(18) However, our results show that the vasa vasorum have proliferated 
markedly into the plaques (IPN), rather than being reduced, favoring an inflammatory process. 
In ‘conventional’ (i.e. non-RT related) atherosclerosis, proliferation of the adventitial vasa 
vasorum is triggered by increased production of hypoxia inducible factor (HIF), a response to 
reduced local oxygen tension due to increased thickness of the intima-media complex. As RT 
is known to cause increased IMT – as we also observed in this study – it is not surprising that 
a greater degree of IPN was observed on the RT side. 
 
Limitations of Current Evidence 
Radiation vasculopathy has been studied previously and many groups have investigated the 
effects of head and/or neck RT upon carotid arteries (imaging studies) and future CVE 
(outcome studies), which have recently been comprehensively reviewed.(19) However, for a 
multitude of reasons, the literature displays marked heterogeneity in this field with a number 
of problems associated with these studies. First, studies that have reported an increased relative 
risk of CVE after RT have either used non-matched control groups or have matched their HNC 
patients to geographically distinct and distant population data(20,21), sometimes derived from 
another country. Studies have not always reported upon stroke sub-type (ischemic or 
hemorrhagic) (22) and information on CVE has not always been judged by a clinician or by 
brain imaging, but by patient questionnaires.(23) Additionally, though many studies have 
suggested an increased risk of CVE in patients exposed to head/neck RT, at least two studies –
which did have well-matched control groups – did not find an increased risk of CVE on long-
term follow-up.(24,25) Finally, and possibly most importantly, the majority of these studies 
did not provide data on the laterality of the stroke. For example, if the right carotid artery has 
been exposed to RT, a clinically ischemic event would be expected in the right cerebral 
hemisphere and thus produce left sided signs (e.g. paresis, reduced sensation). However, this 
level of detail is not available in many prior research papers (20,22,23); thus, although one 
would assume that an ischemic CVE must be related to the RT-side carotid artery, the data 
confirming this are absent.    
 
As a result of these short-comings in the existing data, several questions regarding radiation 
vasculopathy remain answered, most prominent of which is the mechanism by which RT 
affects the arterial wall and subsequently appears to increase stroke risk. The increased 
frequency of IPN we observed strongly implicates an inflammatory reaction, in keeping with 
conventional models of atherosclerosis. Indeed, IPN is one of several initial defence 
mechanisms in response to atherosclerosis.(26) Of the three layers of the arterial wall, the 
tunica media and adventitia receive blood supply from the vasa vasorum, whereas the tunica 
intima is dependent upon diffusion of oxygen directly from the lumen. With development of 
an atherosclerotic plaque within the intima, the distance between the deeper intimal layers and 
the luminal surface increases, producing hypoxia within the plaque. This stimulates release of 
pro-angiogenic factors that induces proliferation of the adventitial vasa vasorum and growth of 
neo-vessels in an attempt to restore normal oxygen tension. Eventually, the plaque is enveloped 
in extensive vasa vasorum and IPN, a hallmark of atherosclerosis.  
 
 
Clinical Implications 
 
There is increasing evidence that plaque composition is clinically important – independent of 
stenosis severity – in relation to outcome.(27,28) As a result of large international surgical 
trials, carotid endarterectomy is reserved for patients with symptomatic arterial plaques with 
stenosis severity >70-80% as judged by Doppler ultrasound.(29,30) However, it is not known 
whether superior risk stratification could be achieved by accounting for novel markers of 
plaque vulnerability, such as presence or absence of IPN, rather than just lesion severity alone. 
 
Our results demonstrate that patients with RT-related carotid disease have a significant increase 
in IPN, a marker of plaque instability. One would therefore hypothesize that these patients with 
increased IPN are at increased risk of CVE. It is unknown whether surgical removal of these 
plaques, even if only causing mild or moderate stenosis, is preferable to medical therapy alone. 
However, a randomized controlled trial examining this very question appears justified on the 
basis of our findings. 
 
Strengths and Limitations 
 
Our study has certain strengths and limitations that warrant discussion. Strengths include a 
well-defined patient population, blinding of the carotid scanner from side of RT treatment, use 
of the contra-lateral artery as an ‘internal’ self-control and, uniquely, use of a continuous 
intravenous infusion of contrast which, unlike multiple bolus injections, produces a constant 
concentration of microbubbles within the bloodstream.  
 
Limitations include lack of another imaging modality for comparison and the lack of histology 
for verification. However, regarding imaging, CEUS has been shown as an accurate technique 
and carotid MRI, for example, has not been shown to be superior for identification of IPN. It 
is true that carotid MRI can assess more features of a plaque’s composition than CEUS, 
including size of the lipid core and thickness of the fibrous cap. However, these aspects of 
plaque composition were not the primary focus of this research project. Regarding histology, 
these patients had no clinical indication for carotid surgery thus histology was impossible to 
obtain, though previous studies have verified the accuracy of CEUS for accurate identification 
of presence and extent of IPN. 
 
Conclusions 
 
Plaque neovascularization, a pre-cursor to plaque hemorrhage and thus a surrogate for plaque 
instability, is significantly increased in arteries exposed to RT during treatment of HNC. This 
effect of RT upon IPN is independent of all other clinical variables, including age, gender and 
previous treatment with chemotherapy. These results suggest that the atherosclerotic plaques 
of radiation vasculopathy may demonstrate increased vulnerability and this may help to explain 
the greater risk of CVE in this patient population. Long-term follow-up of this patient cohort 
will identify the prognostic impact of IPN in this patient population.  
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FIGURES 
 
 
Figure 1: Examples of B-mode (left), colour Doppler (center) and CEUS (right) 
imaging of the carotid arterial tree 
   
Figure 2:  Long axis example of a large far wall plaque with no IPN detected during 
CEUS (also see Supplementary Movie 1) 
 
  
Figure 3: Long axis example of a large plaque with IPN seen (arrows) during CEUS 
(CCA = Common carotid artery, ICA = Internal Carotid Artery, ECA 
=External Carotid Artery – also see Supplementary Movie 2) 
 
  
Figure 4: Short axis example of a large plaque (P), causing significant reduction in 
lumen (L) diameter, with clear IPN visualized during CEUS (also see 
Supplementary Movie 3) 
 
 
 
 
 
 
 
 
 
 
 
  
 
TABLES 
 
 
 
Table 1: Baseline patient characteristics 
 
 
 
 
Patient characteristics Number (%) 
(n = 49) 
Demographics 
Mean age (yrs±SD) 
 
57±8 
Male gender 34 (69.0) 
Diabetes 4 (8.2) 
Hypertension 13 (26.5) 
Smoker 26 (53) 
Hyperlipidemia 11 (22.4) 
Mean BMI (±SD) 26.3±4.4 
Mean time from RT (years) 5.4±2.5 
Medications  
Anti-hypertensive drugs 13 (26.5) 
Anti-diabetic drugs 4 (8.2) 
HMG Co-A reductase inhibitors (Statins) 11 (22.4) 
Aspirin 13 (26.5) 
Loop or thiazide diuretic 5 (10.2) 
 
 
 
 
 
 
 
 
Table 2: Results of B-mode and CEUS imaging in RT-side and non-RT side arteries 
 
 
 
VARIABLE RT SIDE NON-RT SIDE P VALUE 
 n (%) n (%)  
    
Mean Intima-Media Thickness (mm) 0.77±0.20 0.68±0.16 0.02 
    
Total Number of Plaques 64/87 (74) 23/87 (26) ? 
    
Mean Plaque Area (mm2) 23.1±13.8 21.0±14.5 0.57 
    
Mean Total Plaque Area (mm2) 39.1 28.5 0.25 
    
Per-Patient Basis    
    
Plaque present? 36/49 (73) 17/49 (35) <0.001 
    
IPN detected? 29/36 (81) 7/17 (41) 0.004 
    
Grade 2 IPN detected?  14/36 (39) 2/17 (12) 0.04 
    
Per-Plaque Basis    
    
No. of plaques with IPN detected 48/64 (75) 9/23 (39) 0.002 
    
No. of plaques with IPN category:    
    
Grade 0 16/64 (25) 14/23 (61) 0.002 
Grade 1 28/64 (44) 7/23 (30) 0.26 
Grade 2 20/64 (31) 2/23 (9) 0.03 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Relationship between presence or absence of IPN and patient variables in all patients 
(n=49, left) and RT-side only plaques (n=36, right) 
 
 
         ALL PATIENTS       RT-SIDE ONLY  
 
Variable IPN 
N=30 
(%) 
No IPN 
N=19 
(%) 
p value  IPN 
N=29 
(%) 
No IPN 
N=7 
(%) 
p value 
        
Male Gender 23 (77) 11 (58) 0.17  22 (76) 4 (57) 0.58 
        
Smoking 18 (60) 8 (42) 0.22  18 (62) 2 (29) 0.13 
        
Aspirin use 9 (30) 4 (21) 0.49  8 (28) 2 (29) 0.95 
        
Statin use 7 (23) 4 (21) 0.85  6 (21) 4 (57) 0.05 
        
BMI >25kg/m2 17 (57) 6 (32) 0.80  19 (66) 5 (71) 0.77 
        
RT >5yrs 17 (57) 6 (32) 0.09  17 (59) 3 (33) 0.15 
        
Chemotherapy 13 (43) 9 (47) 0.78  12 (41) 2 (29) 0.53 
 
